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Summary
Two studies were conducted to determine
the effect of long-acting penicillin and/or
levamisole injected at arrival or levamisole
injected on day 1 and/or day 7 on the health
and gain of newly received, highly stressed,
light weight calves.  Levamisole injected at
arrival reduced (P<.05) sickness of newly
arrived calves during the first 5 days.  How-
ever, it did not reduce overall sickness during
the receiving period.  Long-acting penicillin
injected at arrival did not reduce sickness, but
did improve (P<.05) gain of calves during the
growing period.  The combination of
levamisole and long-acting penicillin or the
combination of levamisole on day 1 and day 7
did not reduce morbidity in these highly
stressed calves.
(Key Words:  Antibiotic, Levamisole, Peni-
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Introduction
Calves transported long distances normally
have health problems caused by the stresses of
weaning, marketing, co-mingling, and then
shipping.  Many health products have been
tried on highly stressed calves to reduce mor-
bidity.
Antibiotic injections have been used at
arrival to reduce sickness of calves transported
long distances.  Although levamisole® is
commercially marketed as an anthelmintic
(dewormer), it has been shown to stimulate the
immune system in laboratory animals.  The
objective of these experiments was to deter-
mine the effect of long-acting penicillin and
levamisole on the incidence and severity of
health problems in calves purchased in the
southeastern United States and transported to
eastern Kansas.
Experimental Procedures
In Trial I, 500 mixed-breed steer and bull
calves (323 lb) were purchased over a 14-day
period in the fall from Tennessee, Arkansas,
and Mississippi.  The calves were processed at
arrival, and the bull calves were surgically
castrated.  All calves were vaccinated against
IBR, BVD, PI , and blackleg (7-way), and3
treated for internal and external parasites with
Ivomec®.  During processing, the bulls and
steers were uniformly allotted to the following
treatments:  1) long-acting penicillin (injected
subcutaneously at 2.0 ml/100 lb body wt), 2)
levamisole (injected subcutaneously at 1.0
ml/100 lb body wt), 3) both long-acting peni-
cillin and levamisole, and 4) unmedicated
control.
In Trial II, 437 mixed-breed bull calves
(308 lb) were purchased over a 12-day period
in the fall from Tennessee and Mississippi.
The calves were processed at arrival and
surgically castrated.  The calves were vacci-
nated against IBR, BVD, PI  and blackleg (4-3
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way) and treated for internal and external
parasites with Ivomec.  The calves were
allotted randomly to the following treatments:
1) levamisole on both day 1 and day 7 (in-
jected subcutaneously at 1.0 ml/100 lb body
wt), 2) levamisole on day 1 only,  3)
levamisole on day 7 only, and 4) no
levamisole, control.
During the receiving period, calves were
treated when they appeared sick.  In both
studies, the calves were fed a forage diet of
1/2 alfalfa hay and 1/2 prairie hay, supple-
mented with .5 lb of a 40% protein pellet and
2.5 lb whole corn daily.
Results and Discussion
In Trial I, levamisole reduced (P<.05)
sickness of newly received calves during the
first 5 days (Table 1).  However, no differ-
ence occurred among treatments in overall
sickness or medication days required per
animal purchased.  The reduction in sickness
for the first 5 days supports evidence that
levamisole stimulates the immune system.
The use of long-acting penicillin improved
(P<.05) gain during the extended growing
period but did not reduce sickness or medica-
tions required per animal.  This may have
been caused by a reduction in cattle with
chronic, severe lung damage. 
In Trial II, levamisole injected on day 1
resulted in less (P<.05) sickness and a trend
toward fewer medications required during the
first 5 days (Table 2), but no difference was
observed among treatments for overall sick-
ness or medication requirements per animal
purchased.  Levamisole had no effect on calf
gain.  These results agree with the findings of
Trial I.
In summary, neither levamisole or long-
acting penicillin injected alone or in combina-
tion at arrival nor multiple injections of
levamisole reduced the overall level of sick-
ness in highly stressed calves.  However,
long-acting penicillin injected at arrival im-
proved stocker gain during an 111-day grow-
ing period.
Table 1. Effect of Levamisole and Long-acting Penicillin on Gain and Health of Newly
Received Calves (Trial I)
Penicillin
+
Item Control Levamisole Penicillin Levamisole
No. calves 125 125 125 125
Daily gain, lb
   Day 1 to 34 1.44 1.63 1.61 1.63
   Day 34 to 111 2.06 2.04 2.15 2.11a a b b
Morbidity, %
   Day 1 to 5 27.50 18.50 26.50 19.00b a b a
   Day 6 to 34 36.50 42.50 38.60 41.00
   Day 1 to 34 64.00 61.00 65.10 60.00
Medication days/animal purchased:
   Day 1 to 5 .60 .13 .73 .13b a b a
   Day 6 to 34 2.80 3.18 2.90 2.80
   Day 1 to 34 3.40 3.31 3.63 2.93
Means in the same row with unlike superscripts are different (P<.05).ab
Table 2. Effect of Levamisole on Gain and Health of Newly Received Calves (Trial II)
Levamisole Levamisole Levamisole
injected injected injected
Item                   Control                day1             day7       day1 &  day7 
No. calves               110                 109                 109               109    
Daily gain, lb
(day 1 to 30)               1.43                     1.41                   1.31              1.35   
Morbidity, %:
Day 1 to 5                       11.5                        4.5                           10.7b                  5.6     b a a
Day 6 to 30                           39.7                          46.4                               42.6                      46.8    
Day 1 to 30                              51.2                               50.9                                  53.3                    52.4     
Day 1 to 5 .14                     .01                         .18 .13
Day 6 to 30                           2.64                           3.04                                 3.16                             2.55
Day 1 to 30                                  2.79                              3.05                                    3.35                               2.68    
Mortality, % 1.2                   1.0                          3.1 3.6
abMeans in the same row with unlike superscripts are different (P<.05). 
